Missed Opportunities: 10 Questions We Wish Senators Had Asked At The Drug Pricing Hearing

Getting seven top pharma leaders in the same room, required to answer tough questions on drug pricing, is rare. Members of the Senate Finance Committee got that opportunity recently, but there are some questions our Pink Sheet reporters think they missed.